Utilization of sperm cryopreservation in patients with testicular cancer
Journal of Cancer Research and Clinical Oncology · 2024
DOI: 10.1007/s00432-024-05725-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cancer Research and Clinical Oncology, 2024. Verfasst von Viktoria Menzel und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Medical Faculty Carl Gustav Carus, TU Dresden, Fetscherstr. 74, 01307, Dresden, Germany. viktoria.menzel@ukdd.de. Hauptthemen laut MEDLINE: Testicular Neoplasms, Neoplasms, Germ Cell and Embryonal. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Technische Universität Dresden.
Abstract (Originalsprache)
Purpose
We assessed factors that affect the utilization of sperm cryopreservation before 2021, when patients covered expenses, and the influence on quality of life.
Methods
Between 2011 and 2021, testicular cancer survivors (TCS) at our clinic completed a questionnaire, including EORTC QLQ-TC26, covering sperm cryopreservation, sociodemographic details, post-treatment births, and artificial insemination.
Results
After 5.7 ± 3.0 years, 279 participants (64%) responded to the questionnaire. Among them, 33% (91/279) of testicular cancer survivors chose sperm cryopreservation prior to treatment, with 11% (10/91) using it for insemination. Conversely, 2% (3/188) without cryopreservation reported unfulfilled desire to have children. Univariate analysis showed TCS with cryopreservation were younger (30.6 ± 7.1 (35 (21–59)) vs. 42.4 ± 10.9 (48 (22–81)) years; p = 0.001), had a lower BMI (24.2 ± 3.3 vs. 26.6 ± 4.6 kg/m 2 ; p = 0.009) and a lower Charlson Score (> 3: 36% vs. 60%; p < 0.001). Multivariate analysis revealed older age (≥ 37 years: OR 13.1 (5.5–31.2), p < 0.001) and lower education (middle school or less: OR 3.3 (1.6–6.9), p = 0.001) as independent factors associated with not undergoing cryopreservation. Regarding quality of life, multivariate analysis identified a lower infertility anxiety score (OR 4.3 (2.0–9.0), p < 0.001) and higher age (≥ 44 years: OR 5.4 (2.6–11.3); p < 0.001) as predictors for the absence of prior cryopreservation.
Conclusions
Age and education seem to impact the choice of undergoing paid sperm cryopreservation. Urologists should inform testicular cancer patients about costs and coverage. Importantly, the occurrence of unmet desires for parenthood is minimal among those who forego cryopreservation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Medical Faculty Carl Gustav Carus, TU Dresden, Fetscherstr. 74, 01307, Dresden, Germany. viktoria.menzel@ukdd.de.
- Department of Urology, Medical Faculty Carl Gustav Carus, TU Dresden, Fetscherstr. 74, 01307, Dresden, Germany.
Förderung
- Technische Universität Dresden
Zitieren
APA
Menzel, V., Richter, E., Helke, C., Bürk, B. T., Erb, H. H. H., Leike, S., Borkowetz, A., Thomas, C., & Baunacke, M. (2024). Utilization of sperm cryopreservation in patients with testicular cancer. Journal of Cancer Research and Clinical Oncology. https://doi.org/10.1007/s00432-024-05725-2
Vancouver
Menzel V, Richter E, Helke C, Bürk BT, Erb HHH, Leike S, et al. Utilization of sperm cryopreservation in patients with testicular cancer. Journal of Cancer Research and Clinical Oncology. 2024. doi:10.1007/s00432-024-05725-2
BibTeX
@article{Menzel2024,
author = {Menzel, Viktoria and Richter, Emilia and Helke, Charlotte and Bürk, Björn Thorben and Erb, Holger H H and Leike, Steffen and Borkowetz, Angelika and Thomas, Christian and Baunacke, Martin},
title = {Utilization of sperm cryopreservation in patients with testicular cancer},
journal = {Journal of Cancer Research and Clinical Oncology},
year = {2024},
doi = {10.1007/s00432-024-05725-2}
}
EUVIMED